CDT EQUITY INC. Line of Credit Facility, Interest Rate During Period
CDT EQUITY INC. (CDT) had Line of Credit Facility, Interest Rate During Period of 9.50% as of 2024-03-04, per its 10-Q/A filed 2024-11-14.
Financial Statements › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2024-11-14
- 2024-03-04: Line of Credit Facility, Interest Rate During Period 9.50%.
| Period end | Line of Credit Facility, Interest Rate During Period |
|---|---|
| 2024-03-04 | 9.50% 10-Q/A · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |